Fig. 10

Drug susceptibility analysis of different risk groups. (A) Association between two risk groups and sensitivity of Bcl-2 inhibitors. (B) Relationship between two risk groups and Mcl − 1 inhibitors. (C) Correlation of two risk groups with sensitivity of PI3K inhibitors